This test is performed during product development to validate the tablet's design. The strict limits ensure that a patient splitting a tablet receives a dose that is highly accurate, regardless of which half they take.
Uncoated tablets containing acid substances and carbonates which react rapidly in water to release carbon dioxide. Soluble and Dispersible Tablets:
No standard is perfect, and monograph 0478 has limitations. Critics note that it focuses primarily on quality control at the end of production, rather than on process analytical technology (PAT) or real-time release. Moreover, for complex tablets (e.g., modified-release, multilayer, or paediatric mini-tablets), additional monographs or supplementary tests are required. Some argue that the disintegration test is outdated for modern immediate-release formulations, as dissolution testing alone could suffice. Nevertheless, the monograph’s periodic revision process (each new edition every 3–4 years) allows these concerns to be addressed over time.
Optimize binder selection; maintain correct moisture equilibrium during granulation. Acceptance Value (AV) ≤15is less than or equal to 15 Acceptance Value (AV) ≤5is less than or equal to 5 european pharmacopoeia ph eur monograph tablets 0478 better
It forces you to control your granulation, predict your dissolution, and prove your uniformity. While the USP might allow a Cpk of 1.0, Ph. Eur. 0478 silently demands a Cpk of 1.33. That is the difference between a passable doctor and a reliable one.
It provides a harmonized language for industry, regulatory agencies, and pharmacists, making it easier to determine which test applies to which tablet type.
Implementing QbD principles means defining a Critical Quality Attribute (CQA)—such as a 15-minute disintegration target under Monograph 0478—and designing the formulation and process parameters to guarantee that outcome. By understanding the design space, manufacturers reduce batch failures and optimize production efficiency. Process Analytical Technology (PAT) This test is performed during product development to
For orodispersible tablets, 0478 specifies a specific disintegration medium (usually water at 15–25°C). Using a buffer can artificially speed up disintegration, leading to a false pass.
The monograph establishes a strict framework for several categories of oral tablets, including uncoated, coated, gastro-resistant, and modified-release types.
A significant area of focus in the revised monograph is the subdivision of tablets. The requirements are clear and strict, and a European study found that . This is a prime area for "better" execution. Soluble and Dispersible Tablets: No standard is perfect,
I can also help you understand which dissolution method (2.9.3) is recommended for your product.
Compare your existing specifications to Chapter 2.9.40 (Uniformity of Dosage Units) and 2.9.3 (Dissolution) referenced in 0478. Identify gaps in your dissolution apparatus calibration.